Document
IPR2017-00570, No. 1004-2 Exhibit - Exhibit 10042 556 FH2 (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00570, No. 1004-2 Exhibit - Exhibit 10042 556 FH2 (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00570, No. 1021 Exhibit - Exhibit 1021 Small (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00570, No. 1021 Exhibit - Exhibit 1021 Small (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00570, No. 1006 Exhibit - Exhibit 1006 Ding 979 (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00570, No. 1006 Exhibit - Exhibit 1006 Ding 979 (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00570, No. 1031 Exhibit - Exhibit 1031 556 Institution Decision (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00570, No. 1031 Exhibit - Exhibit 1031 556 Institution Decision (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00570, No. 1013 Exhibit - Exhibit 1013 PDR (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00570, No. 1013 Exhibit - Exhibit 1013 PDR (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00570, No. 1005 Exhibit - Exhibit 1005 857 FH (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00570, No. 1005 Exhibit - Exhibit 1005 857 FH (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Review (Orange Book Oct. 27, 2016)
Cite Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Review (Orange Book Oct. 27, 2016)
+ More Snippets
Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Label (Orange Book Oct. 27, 2016)
Cite Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Label (Orange Book Oct. 27, 2016)
+ More Snippets
Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Label (Orange Book Oct. 27, 2016)
Cite Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Label (Orange Book Oct. 27, 2016)
+ More Snippets
Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Review (Orange Book Oct. 27, 2016)
Cite Document
RESTASIS MULTIDOSE and RESTASIS, 050790, Review (Orange Book Oct. 27, 2016)
+ More Snippets
Document
IPR2016-01129, No. 2012-29 Exhibit - Damato et al, Senile Atrophy of the Human Lacrimal Gland The Contribution of Chronic Inflammatory Disease (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2012-29 Exhibit - Damato et al, Senile Atrophy of the Human Lacrimal Gland The Contribution of Chronic Inflammatory Disease (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2070-68 Exhibit - Calfee, Winston, and Stempski, Direct to Consumer Advertising and the Demand for Cholesterol Reducing Drugs (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2070-68 Exhibit - Calfee, Winston, and Stempski, Direct to Consumer Advertising and the Demand for Cholesterol Reducing Drugs (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2069-67 Exhibit - Bradford, Kleit, Nietert, et al, How Direct to Consumer Television Advertising for Osteoarthritis Drugs Affect Physicians Prescribing Behavior (P.T.A.B. Mar....
Cite Document
IPR2016-01129, No. 2069-67 Exhibit - Bradford, Kleit, Nietert, et al, How Direct to Consumer Television Advertising for Osteoarthritis Drugs Affect Physicians Prescribing Behavior (P.T.A.B. Mar. 20, 2
+ More Snippets
Document
IPR2016-01129, No. 2016-33 Exhibit - Power et al, Effect of Topical Cyclosporin A on Conjunctival T Cells in Patients with Secondary Sjgrens Syndrome (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2016-33 Exhibit - Power et al, Effect of Topical Cyclosporin A on Conjunctival T Cells in Patients with Secondary Sjgrens Syndrome (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2031-47 Exhibit - Allergan NYSE AGN Company Profile (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2031-47 Exhibit - Allergan NYSE AGN Company Profile (P.T.A.B. Mar. 20, 2017)
+ More Snippets